Abstract
We previously reported the discovery of diphenylimidazoles as potent sodium channel blockers, potentially useful in the treatment of epilepsy. In this work we further explore the structural requirements necessary for the potency of these derivatives with the aim to understand which structural modifications of the original scaffold could be tolerated in order to retain activity. We have synthesized new compounds working on the 2-position of the imidazole ring. First we have introduced a carbonyl spacer, that was subsequently reduced to alcohol. Both carbonyl and alcohol derivatives have been tested for their ability to block NaV1.6 sodium channel subtype in vitro and for their antiepileptic activity in rodent acute seizures models.
Keywords: Sodium channels, patch clamp electrophysiology, NaV1.6, Phenyl-imidazoles.
Letters in Drug Design & Discovery
Title:Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives
Volume: 13 Issue: 9
Author(s): Mirko Rivara, Manoj K. Patel, Alberto Rapalli and Valentina Zuliani
Affiliation:
Keywords: Sodium channels, patch clamp electrophysiology, NaV1.6, Phenyl-imidazoles.
Abstract: We previously reported the discovery of diphenylimidazoles as potent sodium channel blockers, potentially useful in the treatment of epilepsy. In this work we further explore the structural requirements necessary for the potency of these derivatives with the aim to understand which structural modifications of the original scaffold could be tolerated in order to retain activity. We have synthesized new compounds working on the 2-position of the imidazole ring. First we have introduced a carbonyl spacer, that was subsequently reduced to alcohol. Both carbonyl and alcohol derivatives have been tested for their ability to block NaV1.6 sodium channel subtype in vitro and for their antiepileptic activity in rodent acute seizures models.
Export Options
About this article
Cite this article as:
Rivara Mirko, Patel K. Manoj, Rapalli Alberto and Zuliani Valentina, Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives, Letters in Drug Design & Discovery 2016; 13 (9) . https://dx.doi.org/10.2174/1570180813666160714125755
DOI https://dx.doi.org/10.2174/1570180813666160714125755 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Therapeutics of HBV
Current Gene Therapy Novel 3-Substituted-2, 3-Dihydro-2-Thioxoquinazolin-4-(1H)-one derivative as Anticonvulsants: Synthesis, Molecular Docking and Pharmacological Screening
Letters in Drug Design & Discovery Evaluating Drug Safety in Children and Adolescents with Bipolar Disorder
Current Drug Safety Structure-to-function Relationship of Carbohydrates in the Mechanism of Lysosomal Storage Disorders (LSDs)
Current Organic Chemistry Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research Genes Involved in Hereditary Hearing Impairment
Current Genomics Modulation and Absorption of Xenobiotics: The Synergistic Role of CYP450 and P-gp Activities in Cancer and Neurodegenerative Disorders
Current Drug Metabolism Subject Index To Volume 9
Current Medicinal Chemistry A Review on Mechanistic and Pharmacological Findings of Diabetic Peripheral Neuropathy including Pharmacotherapy
Current Diabetes Reviews Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy
Current Medicinal Chemistry Barbiturates: A Review of Synthesis and Antimicrobial Research Progress
Current Organic Synthesis Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update
Current Drug Metabolism Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy Studies on Chloride Channels and their Modulators
Current Topics in Medicinal Chemistry Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Current Drug Targets Potential Therapeutic Relevance of Adenosine A2B and A2A Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets